Radiation optic neuropathy after external beam radiation therapy for acromegaly

Radiotherapy and Oncology

Volumn 68, Issue 2, 2003, Pages 95-100

  Van Den Bergh, Alfons C M ^a   Dullaart, Robin P F ^a   Hoving, Marjanke A ^a   Links, Thera P ^a   Ter Weeme, Cees A ^a   Szabó, Ben G ^a   Pott, Jan Willem R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID;

ACROMEGALY; AGE DISTRIBUTION; BEAM THERAPY; BLOOD BRAIN BARRIER; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HYPERBARIC OXYGEN; HYPOPHYSIS ADENOMA; INCIDENCE; OPTIC NERVE DISEASE; OXYGEN THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; TREATMENT OUTCOME; RADIATION INJURY; RADIOTHERAPY;

ACROMEGALY; HUMANS; OPTIC NERVE DISEASES; RADIATION INJURIES; RADIOTHERAPY; RISK FACTORS;

EID: 1542709654     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00202-0     Document Type: Review

References (84)

1. Al-Mefty O., Kersh J.E., Routh A., Smith R.R. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg. 73:1990;502-512.
2. Alexander L., Appleton D., Hall R., Ross W.M., Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol. 12:1980;71-79.
3. Aloia J.F., Field R.A., Kramer S. Treatment of acromegaly. Arch Intern Med. 131:1973;509-515.
4. Aloia J.F., Roginsky M.S., Archambeau J.O. Pituitary irradiation in acromegaly. Am J Med Sci. 267:1974;81-87.
5. Aristizabal S., Caldwell W.L., Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys. 2:1977;667-673.
6. Atkinson A.B., Allen I.V., Gordon D.S., et al. Progressive visual failure in acromegaly following external pituitary adenoma. Clin Endocrinol. 10:1979;469-479.
7. Baldwin A., Cundy T., Butler J. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinol. 108:1985;26-30.
8. Barceló B., Pérez C., Dávila N., Lucas T., Salto L., Alcañiz J. Valoración endocrinológica de 61 pacientes acromegálicos tratados con cirugía transesfenoidal aislada, o asociada a telecobaltoterapia y/o bromocriptina. Med Clin. 80:1982;735-741.
9. Bataini J.P., Glinski B. Supervoltage irradiation in the management of pituitary adenomas. Derome P.J., Jedyak C.P., Peillon F. Pituitary adenomas. 1980;203 Asclepios Publishers, Paris.
10. Bengtsson B., Edén S., Ernest I., Odén A., Sjögren B. Epidemiology and long-term survival in acromegaly. Acta Med Scand. 223:1988;327-335.
11. Bergh van den ACM, Hoving MA, Links TP, et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Short communication. Radiother Oncol, 2003;68:101-3.
12. Béclère M.A. Radiotherapie, techniques, résultats indications et contre-indications de la roentgenthérapie des tumeurs hypophysiares. Rev Neurol. 1922;808-817.
13. Bloom B., Kramer S. Conventional radiation therapy in the management of acromegaly. McL.Black P., et al. Secretory tumors of the pituitary gland (progress in endocrine research and therapy). 1st ed. 1984;179-190 Raven Press, New York.
14. Borruat F.-X., Schatz N.J., Glaser J.S. Neuropathie optique retrobulbaire post-actinique. Klin Monatsbl Augenheilkd. 208:1996;381-384.
15. Borruat F.-X., Schatz N.J., Glaser J.S., Feun L.G., Matos L. Visual recovery from radiation-induced optic neuropathy. J Clin Neuro-opthalmol. 13:1993;98-101.
16. Bringer J., Klawatsch D., Jaffiol C., Orsetti A., Robin M., Mirouze J. Comparaison de diverses therapeutiques de l'acromegalie tumorale. Annales d' endocrinologie. 44:1983;107-114.
17. Chang C.H. Radiotherapy of secretory and nonsecretory pituitary adenomas. Chang C.H., Honaspian E.M. Tumours of the central nervous system: modern radiotherapy in multidisciplinary management. 1982;201-213 Mason, New York.
18. Ciccarelli E., Valetto M.R., Vasario E., Avataneo T., Grottoli S., Camanni F. Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Endocrinol Invest. 16:1993;565-572.
19. Clarke S.D., Woo S.Y., Butler E.B., et al. Treatment of secretory pituitary adenoma with radiation therapy. Radiology. 188:1993;759-763.
20. Colby M.Y., Kearns T.P. Radiation therapy of pituitary adenomas with associated visual impairment. Staff Meetings of the Mayo Clinic. 37:1962;15-24.
21. Cozzi R., Barausse M., Asnaghi D., Dallabonzana D., Lodrini S., Attanasio R. Failure of radiotherapy in acromegaly. Eur J Endocrinol. 145:2001;717-726.
22. Davis D.H., Laws E.R., Ilstrup D.M., et al. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg. 79:1993;70-75.
23. Dowsett R.J., Fowble B., Sergott R.C., et al. Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys. 19:1990;453-459.
24. Eastman R.C., Gorden P., Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab. 48:1978;931-940.
25. Eastman R.C., Gordon P., Glatstein E., Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am. 21:1992;693-712.
26. Effenterre V.R., Boch A.-L. Radionécrose du chiasma, étude clinique et radiologique. A propos de trois cas. Neurochirurgie. 39:1993;75-84.
27. Emmanuel I.G. Symposium on pituitary tumours (3) historical aspects of radiotherapy, present treatment technique and results. Clin Radiol. 17:1966;154-160.
28. Epaminonda P., Porretti S., Vincenzo C., Beck-Peccoz P., Faglia G., Arosia M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol. 55:2001;183-189.
29. Feek C.M., McLelland J., Seth J., et al. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumours? Clin Endocrinol. 20:1984;401-408.
30. Forrest A.P.M., Peebles Brown D.A., Morris S.R., Illingworth C.F.W. Pituitary radon implant for advanced cancer. Lancet. 270:1956;399-401.
31. Giovanelli M.A., Gaini S.M., Tomei G., et al. Transsphenoidal microsurgical treatment of acromegaly. Lancet. 270:1984;215-224.
32. Goffman T.E., Dewan R., Arakaki R., Gorden P., Oldfield E.H., Glatstein E. Persistent or recurrent acromegaly. Cancer. 69:1992;271-275.
33. Gorden P., Glatstein E., Oldfield E.H., et al. Conventional supervoltage radiation in the treatment of acromegaly. Robbins R.J.M.S. Acromegaly. A century of scientific and clinical progress. 1987;211 Kluwer/Plenum Publishers, New York.
34. Gordon D.A., Hill F.M., Ezrin C. Acromegaly: a review of 100 cases. Can Med Assoc J. 87:1962;1106-1109.
35. Gramegna A. Un cas d'acromégalie traité par la radiothérapie. Rev Neurol. 17:1909;15-17.
36. Grattan-Smith P.J., Morris J.G., Langlands A.O. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psychiatry. 55:1992;949-955.
37. Gutt B., Hatzack C., Morrison K., Pollinger Band Schopohl J. Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. Eur J Endocrinol. 144:2001;109-116.
38. Guy J., Mancuso A., Beck R., et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg. 74:1991;426-432.
39. Hammer H.M. Optic chiasmal radionecrosis. Trans Ophthalmol Soc U K. 103:1983;208-211.
40. Hardy J., Somma M., Vezina J.L. Treatment of acromegaly: radiation or surgery? Morley J.P. Current controversies in neurosurgery. 1976;377 W.B. Saunders, New York.
41. Harris J.R., Levene M.B. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 120:1976;167-171.
42. Holdaway I.M., Rajasoorya C. Epidemiology of acromegaly. Pituitary. 2:1999;29-41.
43. Hughes M.N., Llamas K.J., Yelland M.E., Obst D., Tripcony L.B. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int Radiat Oncol Biol Phys. 27:1993;1035-1043.
44. Hunter W.M., Gillingham F.J., Harris P., et al. Serial assays of plasma growth hormone in treated and untreated acromegaly. J Endocrinol. 63:1974;21-34.
45. Jenkins J.S., Ash S., Bloom H.J.G. Endocrine function after external pituitary irradiation in patients with secreting and nonsecreting pituitary tumours. Q J Med, new series. XLI:1972;57-69.
46. Jiang G.L., Tucker S.L., Guttenberger R., et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 30:1994;17-25.
47. Kanis J.A., Gillingham F.J., Harris P., et al. Clinical and laboratory study of acromegaly: assessment before and one year after treatment. Q J Med, new series. XLIII:1974;409-431.
48. Klijn J.G.M., Lamberts S.W.J., Woerkom van-Eijkenboom W.M.H., et al. Long term follow-up after external pituitary irradiation of pituitary adenomas. Lamberts S.W.J., Tilders F.J.H., van der Veen E.A., Assies J. Trends in diagnosis and treatment of pituitary adenomas. 1984;359-372 Free University Press, Amsterdam.
49. Kline L.B., Kim J.Y., Ceballos R. Radiation optic neuropathy. Ophthalmology. 92:1985;1118-1126.
50. Kozak G.P., Vagnucci A.I., Lauler D.P., Thorn G.W. Acromegaly pre- and postpituitary irradiation. Metabolism. 15:1966;290-303.
51. Kramer S. Indications for, and results of, treatment of pituitary tumors by external radiation. Kohler P.O., Ross G.T. Diagnosis and treatment of pituitary tumors. 1973;217-230 American Elsevier Publishing Co, New York.
52. Kundra S.N., Sharma B.S., Banerjee A.K., Ayyagari S., Dhir S.P., Kak V.K. Damage to the anterior visual pathway and brain parenchyma following external pituitary irradiation. Indian J Cancer. 27:1990;172-179.
53. Lam K.S.L., Wang C., Choi P., Ma J.T.C., Yeung R.T.T. Long-term effects of megavoltage radiotherapy. Aust N Z J Med. 19:1989;202-206.
54. Lamberg B.-A., Kivikangas V., Vartiainen J., Raitta C., Pelkonen R. Conventional pituitary irradiation in acromegaly. Acta Endocrinol. 82:1976;267-281.
55. Landolt A.M. Hazards of radiotherapy in patients with pituitary adenomas. Derome P.J., Jedyak C.P., Peillon F. Pituitary adenomas. 1980;227-231 Asclepios Publishers, Paris.
56. Lawrence A.M., Pinsky S.M., Goldfine I.D. Conventional radiation therapy in acromegaly. Arch Intern Med. 128:1971;369-377.
57. Littley M.D., Shalet S.M., Swindell R., Beardwell C.G., Sutton M.L. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol. 32:1990;261-270.
58. Lüdecke D.K., Lutz B.S., Niedworok G. The choice of treatment after incomplete adenomectomy in acromegaly: proton- versus high voltage radiation. Acta Neurochir (Wien). 96:1989;32-38.
59. Macleod A.F., Clarke D.G., Pambakian H., Lowy C., Sonksen P.H., Collins C.D. Treatment of acromegaly by external irradiation. Clin Endocrinol. 30:1989;303-314.
60. McCollough W.M., Marcus R.B., Rhoton A.L., Ballinger W.E., Million R.R. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after ≥4500 cGy. Int J Radiat Oncol Biol Phys. 21:1991;607-614.
61. Melmed S., Jackson I., Kleinberg D., Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab. 83:1998;2646-2652.
62. Millar J.L., Spry N.A., Lamb D.S., Delahunt J. Blindness in patients after external beam irradiation for pituitary adenomas: two cases occurring after small daily fractional doses. Clin Oncol. 3:1991;291-294.
63. Movsas B., Movsas T.Z., Steinberg S.M., Okunieff P. Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys. 33:1995;599-605.
64. O'Halloran D.J., Shalet S.M. Acromegaly: unravelling a complex disease. Growth Regul. 5:1995;119-124.
65. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., Million R.R. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 30:1994;755-764.
66. Pistenma D.A., Goffinet D.R., Bagshaw M.A., Hanbery J.W., Eltringham J.R. Treatment of acromegaly with megavoltage radiation therapy. Int J Radiat Oncol Biol Phys. 1:1976;885-893.
67. Powell J.S., Wardlaw S.L., Post K.D., Freda P.U. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab. 85:2000;2068-2071.
68. Rivoal O., Brézin A.P., Feldman-Billard S., Luton J.-P. Goldmann perimetry in acromegaly. Ophthalmology. 107:2000;991-997.
69. Roden D., Bosley T.M., Fowble B., et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm. Ophthalmology. 97:1990;346-351.
70. Ross D.A., Wilson C.B. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg. 68:1988;854-867.
71. Salinger D.J., Brady L.W., Miyamoto C.T. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol. 15:1992;467-473.
72. Schatz N.J., Lichtenstein S., Corbett J.J. Delayed radiation necrosis of the optic nerves and chiasm. Glaser J.S., Smith J.L. Neuro Ophthalmology Symposium of the University of Miami and the Bascom Palmer Eye Institute. 8th ed. 1975;131-139 CV Mosby, St. Louis.
73. Sheline G.E., Goldberg M.B., Feldman R. Pituitary irradiation for acromegaly. Radiology. 76:1961;70-75.
74. Shih T.-Y., Wei C.-P., Lui C.-C., Leung W. Magnetic resonance imaging of radiation necrosis after radiotherapy for acromegaly: report of a case. J Formos Med Assoc. 93:1994;78-80.
75. Speirs C.J., Reed P.I., Morrison R., Joplin G.F. The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinol. 122:1990;559-565.
76. Thalassinos N.C., Tsagarakis S., Ioannides G., Tzavara I., Papavasilou C. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: a long term follow-up study. Eur J Endocrinol. 138:1998;160-163.
77. Trampe af E., Lundell G., Lax I., Werner S. External irradiation of growth hormone producing pituitary adenomas: prolactin as marker of hypothalamic and pituitary effects. Int J Radiat Oncol Biol Phys. 20:1990;655-660.
78. Tran L.M., Blount L., Horton D., Sadeghi A., Parker R.G. Radiation therapy of pituitary tumors: results in 95 cases. Am J Clin Oncol. 14:1991;25-29.
79. Tsang F.W., Brierley J.D., Panzarella T., Gospodarowicz M.K., Sutcliffe S.B., Simpson W.J. Role of radiation therapy in clinically hormonally-active pituitary adenomas. Radiother Oncol. 41:1996;45-53.
80. Wambersie A. ICRU report 62; prescribing, recording and reporting photon beam therapy (Supplement to ICRU 50); 1999.
81. Wass J.A.H., Plowman P.N., Jones A.E. The treatment of acromegaly by external pituitary irradiation and drugs. Lüdecke D.K.T.G. Growth hormone growth factors, and acromegaly. 1987;199 Raven Press, New York.
82. Werder V.K., Eversmann T., Fahlbusch R. Endocrine-active pituitary adenomas: long-term results of medical and surgical treatment. Camanni F., Müller E.E. Pituitary hyperfunction: physiopathology and clinical aspects. 1984;385-406 Raven Press, New York.
83. Werner S., Trampe E., Palacios P., Lax I., Hall K. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation. Int J Radiat Oncol Biol Phys. 11:1985;1713-1720.
84. Zaugg M., Adaman O., Pescia R., Landolt A.M. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-50 Gy. Int J Radiat Oncol Biol Phys. 32:1995;671-680.